Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia.

Bone marrow transplantation - 1 Mar 1996

Aversa F, Terenzi A, Tabilio A, Velardi A, Falzetti F, Felicini R, Carotti A, Ruggeri L, Reisner Y, Martelli M F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Bone Marrow Transplantation
Share to Graft vs Host Disease
Share to Granulocyte Colony-Stimulating Factor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lymphocyte Count

Share to Pilot Projects

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to T-Lymphocyte Subsets

Source

Identifiers

PMID: 8722339

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia.PMID 8722339Read ↗

PBPC grafts from healthy donors: analysis of CD34+ and CD3+ subpopulations.Semantic proximity Read ↗

[Non-side population hematopoietic stem cells in mouse bone marrow].Semantic proximity Read ↗

Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies.Semantic proximity Read ↗

Identification of immune-activated hematopoietic stem cells.Semantic proximity Read ↗

Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translationSemantic proximity Read ↗

Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantationSemantic proximity Read ↗

Use of human AML cells to study graft-versus-leukemia immunity in xenogeneic mouse models of GVHDSemantic proximity Read ↗

Characterization of CD34+ cells mobilized to the peripheral blood during the recovery from cyclophosphamide chemotherapy.Semantic proximity Read ↗

Haploidentical ‘megadose’ CD34+ cell transplants for patients with acute leukemiaSemantic proximity Read ↗

Bone marrow transplantation across HLA barriers by increasing the number of transplanted cellsSemantic proximity Read ↗

Acute GVHD after allogeneic hematopoietic transplantation affects early marrow reconstitution and speed of engraftmentSemantic proximity Read ↗

Directed Differentiation of Mobilized Hematopoietic Stem and Progenitor Cells into Functional NK cells with Enhanced Antitumor Activity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.